Fig. 3From: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysisMean difference in total dose of gonadotrophins (a), number of oocytes retrieved (b) and duration of ovarian stimulation (c) with biosimilar preparations of follitropin alfa versus the reference productBack to article page